Ratio Therapeutics

0 followers


A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.

Industries

Headquarters

Employees

Links

Org chart

Jack Hoppin
Chairman & CEO

Jack Hoppin

Collapse
John Babich
Director, President, & Chief Scientific Officer
Jacob Hesterman
Chief Data Officer
John M. Garvey
Chief Legal Officer & General Counsel
Matthias Friebe
Chief Technology Officer
Stephen Dimagno
Head, Chemistry
Kelly Orcutt
Head, Pharmacology
Allan Green
Director & Regulatory Consultant
Bill Cupelo
Chief Business Officer
Robyn T.
Financal Operations Specialist